苑东生物(688513.SH)：盐酸纳呋拉啡口崩片获得药品注册证书

Core Viewpoint - Yuan Dong Bio (688513.SH) has received the drug registration certificate for its hydrochloride nafurolafine orally disintegrating tablets from the National Medical Products Administration, indicating compliance with drug registration requirements and marking a significant milestone for the company [1] Group 1 - The active ingredient of the hydrochloride nafurolafine orally disintegrating tablets is hydrochloride nafurolafine, classified as a second-class psychoactive drug under national regulations [1] - The indication for the drug is to improve itching in patients undergoing hemodialysis, specifically for cases where existing treatments are ineffective [1] - The drug was registered under the category of chemical drugs type 4, and its approval is considered equivalent to passing the consistency evaluation [1] Group 2 - The approval of this drug is not expected to have a significant impact on the company's recent performance [1]